Skip to main content
. 2019 May 24;18(3):632–638. doi: 10.5114/aoms.2019.85348

Table I.

Characteristics of the patients

Parameter RF group (n = 24) PVAC group (n = 46) CB group (n = 24) nMARQ group (n = 10) P-value
Baseline characteristics:
 Age [years]* 58.0 ±9.15 60.7 ±8.8 59.7 ±10.3 61.4 ±12.1 0.49
 Male 17 (71%) 34 (74%) 19 (79%) 8 (80%) 0.89
 BMI [kg/m2]* 28.6 ±2.4 27.5 ±2.6 26.8 ±6.0 27.6 ±2.3 0.42
 Heart failure 1 (4.2%) 1 (2.2%) 0 (0%) 1 (10%) 0.43
 Hypertension 18 (75%) 32 (70%) 18 (75%) 8 (80%) 0.89
 Diabetes 4 (17%) 10 (22%) 6 (25%) 2 (20%) 0.91
 Previous stroke 2 (8.3%) 2 (4.3%) 2 (8.3%) 0 (0%) 0.60
 CHA2DS2-VASc score* 1.6 ±1.6 1.7 ±1.2 1.8 ±1.4 1.9 ±0.9 0.74
 LA diameter [mm]* 43.0 ±4.6 42.8 ±3.3 42.5 ±2.6 43.7 ±2.8 0.48
 LV ejection fraction (%)* 62.9 ±5.0 60.3 ±4.7 63.2 ±5.2 60.2 ±5.2 0.07
 Persistent AF 3 (13%) 3 (7%) 2 (8%) 1 (10%) 0.87
Procedural characteristics:
 Procedure time [min]* 167.1 ±30.7 110.5 ±19.7 106.0 ±20.2 141.5 ±24.3 < 0.001
 LA dwell time [min]* 101.5 ±22.5 53.9 ±8.0 56.0 ±9.0 97.0 ±20.9 < 0.001
 Fluoro time [min]* 22.7 ±10.6 15.9 ±5.9 16.3 ±8.5 15.3 ±5.2 0.048
 Complications (minor) 3 (13%) 3 (7%) 2 (8%) 1 (10%) 0.87
*

Data presented as mean ± SD;

BMI – body mass index, LA – left atrium, LV – left ventricle, AF – atrial fibrillation.